Erdafitinib (JNJ-42756493) CAS:1346242-81-6
 Erdafitinib (JNJ-42756493)
Erdafitinib (JNJ-42756493)   
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-C-1984 | 100mg | 225.00 | + Add to cart | |
| R-C-1984 | 200mg | 400.00 | + Add to cart | |
| R-C-1984 | 500mg | 800.00 | + Add to cart | |
|  | ||||
Product description
							Erdafitinib(JNJ-42756493)is a potent and selective orally bioavailable,pan fibroblast growth factor receptor(FGFR)inhibitor with potential antineoplastic activity.JNJ-42756493 binds to and inhibits FGFR,which may result in the inhibition of FGFR-related signal transduction pathways and thus the inhibition of tumor cell proliferation and tumor cell death in FGFR-overexpressing tumor cells.FGFR,upregulated in many tumor cell types,is a receptor tyrosine kinase essential to tumor cell proliferation, differentiation and survival.
 
								| Appearance | N/A | 
|---|---|
| Molecular Weight | N/A | 
| purity | >95% | 
| PDI by GPC | <1.5 | 
| Solubility | N/A | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 3 weeks | 
| Stability | 1 year | 
Document
							Related Product
							
						
 Items-$0.00
Items-$0.00

 Email:
Email: Tel.:
Tel.: msds---Erdafitinib (JNJ-42756493)
msds---Erdafitinib (JNJ-42756493)     RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                 Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                 Tel:  02988811435
                    Tel:  02988811435
                 Fax: (86-29)8881-1435
                    Fax: (86-29)8881-1435
                 Email: sales@ruixibiotech.com
                    Email: sales@ruixibiotech.com
                 Web: http://www.ruixibiotech.com
                    Web: http://www.ruixibiotech.com    
					
							
                

